Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions
Early diagnosis and positive outcomes of retinoblastoma in childhood have been positively correlated with the economic wealth of high-income countries (HICs) worldwide. Adequate curability and survival rates, adherence to treatment, presence of poor prognostic initial clinical signs, and metastatic...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/1953602 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556796930162688 |
|---|---|
| author | Lucas A. Garza-Garza Raúl E. Ruiz-Lozano Genaro Rebolledo-Méndez Ismael Ibarra-Nava Héctor J. Morales-Garza David Ancona-Lezama |
| author_facet | Lucas A. Garza-Garza Raúl E. Ruiz-Lozano Genaro Rebolledo-Méndez Ismael Ibarra-Nava Héctor J. Morales-Garza David Ancona-Lezama |
| author_sort | Lucas A. Garza-Garza |
| collection | DOAJ |
| description | Early diagnosis and positive outcomes of retinoblastoma in childhood have been positively correlated with the economic wealth of high-income countries (HICs) worldwide. Adequate curability and survival rates, adherence to treatment, presence of poor prognostic initial clinical signs, and metastatic disease at diagnosis appear to have a less favorable picture in low-income countries (LICs). However, this is not always the case. An example is Argentina, where disease-free survival rates of retinoblastoma are notably higher than expected when taking into consideration its economic situation. Unfortunately, as in other Latin American LICs, retinoblastoma outcomes in Mexico are worrisome. Interestingly, the Human Development Index (HDI) in Mexico varies widely between its different geographical regions. While in some states, the HDI resembles those of high-income countries, and in others, the opposite is observed. A unifying picture of Mexico’s developmental status, health resources, indicators, and other factors possibly influencing outcomes in retinoblastoma is currently unavailable. The present review explores the previously mentioned factors in Mexico and compares them to other countries. Additionally, it recommends solutions or enhancements where possible. |
| format | Article |
| id | doaj-art-185f3293e7f34b47bc7b47a85a96b247 |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-185f3293e7f34b47bc7b47a85a96b2472025-02-03T05:44:16ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/19536021953602Challenge of Retinoblastoma in Mexico in 2020: Perspectives and SolutionsLucas A. Garza-Garza0Raúl E. Ruiz-Lozano1Genaro Rebolledo-Méndez2Ismael Ibarra-Nava3Héctor J. Morales-Garza4David Ancona-Lezama5Tecnologico de Monterrey, School of Medicine and Health Sciences, Ocular Oncology Service at Institute of Ophthalmology and Visual Sciences, Hospital Zambrano-Hellion, San Pedro Garza Garcia, Nuevo León, MexicoTecnologico de Monterrey, School of Medicine and Health Sciences, Ocular Oncology Service at Institute of Ophthalmology and Visual Sciences, Hospital Zambrano-Hellion, San Pedro Garza Garcia, Nuevo León, MexicoWriting Lab, TecLabs, Vicerrectoria de Investigación y Transferencia de Tecnología, Tecnologico de Monterrey, Monterrey, MexicoDepartment of Preventive Medicine and Public Health, Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, MexicoTecnologico de Monterrey, School of Medicine and Health Sciences, Ocular Oncology Service at Institute of Ophthalmology and Visual Sciences, Hospital Zambrano-Hellion, San Pedro Garza Garcia, Nuevo León, MexicoTecnologico de Monterrey, School of Medicine and Health Sciences, Ocular Oncology Service at Institute of Ophthalmology and Visual Sciences, Hospital Zambrano-Hellion, San Pedro Garza Garcia, Nuevo León, MexicoEarly diagnosis and positive outcomes of retinoblastoma in childhood have been positively correlated with the economic wealth of high-income countries (HICs) worldwide. Adequate curability and survival rates, adherence to treatment, presence of poor prognostic initial clinical signs, and metastatic disease at diagnosis appear to have a less favorable picture in low-income countries (LICs). However, this is not always the case. An example is Argentina, where disease-free survival rates of retinoblastoma are notably higher than expected when taking into consideration its economic situation. Unfortunately, as in other Latin American LICs, retinoblastoma outcomes in Mexico are worrisome. Interestingly, the Human Development Index (HDI) in Mexico varies widely between its different geographical regions. While in some states, the HDI resembles those of high-income countries, and in others, the opposite is observed. A unifying picture of Mexico’s developmental status, health resources, indicators, and other factors possibly influencing outcomes in retinoblastoma is currently unavailable. The present review explores the previously mentioned factors in Mexico and compares them to other countries. Additionally, it recommends solutions or enhancements where possible.http://dx.doi.org/10.1155/2020/1953602 |
| spellingShingle | Lucas A. Garza-Garza Raúl E. Ruiz-Lozano Genaro Rebolledo-Méndez Ismael Ibarra-Nava Héctor J. Morales-Garza David Ancona-Lezama Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions Journal of Ophthalmology |
| title | Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions |
| title_full | Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions |
| title_fullStr | Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions |
| title_full_unstemmed | Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions |
| title_short | Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions |
| title_sort | challenge of retinoblastoma in mexico in 2020 perspectives and solutions |
| url | http://dx.doi.org/10.1155/2020/1953602 |
| work_keys_str_mv | AT lucasagarzagarza challengeofretinoblastomainmexicoin2020perspectivesandsolutions AT rauleruizlozano challengeofretinoblastomainmexicoin2020perspectivesandsolutions AT genarorebolledomendez challengeofretinoblastomainmexicoin2020perspectivesandsolutions AT ismaelibarranava challengeofretinoblastomainmexicoin2020perspectivesandsolutions AT hectorjmoralesgarza challengeofretinoblastomainmexicoin2020perspectivesandsolutions AT davidanconalezama challengeofretinoblastomainmexicoin2020perspectivesandsolutions |